Lloye Dillon, PhD
About Lloye Dillon, PhD
Lloye Dillon, PhD, is the Director of Global Drug Development at Bristol Myers Squibb in Princeton, NJ, with extensive experience in both academic and industry settings.
Title and Current Role
Lloye Dillon, PhD, is currently the Director of Global Drug Development at Bristol Myers Squibb, based in Princeton, NJ. In this role, he is responsible for overseeing comprehensive drug development processes to ensure the successful delivery of new therapeutics.
Professional Experience at Bristol Myers Squibb
Lloye Dillon has an extensive tenure at Bristol Myers Squibb, beginning as a Research Investigator, Pharmacodiagnostics (2017-2019). He then served as Associate Director, Pharmacodiagnostics (2019-2022), where he led efforts in developing pharmacodiagnostic tools. In 2022, he briefly held the position of Director, Diagnostic Sciences before transitioning to his current role as Director of Global Drug Development.
Academic Roles and Biotech Industry Experience
Before joining Bristol Myers Squibb, Lloye Dillon gained significant academic and industry experience. He served as an Adjunct Assistant Professor in the Department of Biology at UNC Charlotte from 2015 to 2017. Concurrently, he worked at OncoTAb, Inc., a biotech startup, as a Senior Scientist focusing on research and product development. He also completed a postdoctoral fellowship at Dartmouth College's Geisel School of Medicine and Norris Cotton Cancer Center from 2012 to 2014.
Educational Background
Lloye Dillon holds a PhD in Molecular Cell and Developmental Biology from the University of Miami Leonard M. Miller School of Medicine, completed in 2012. He also has a Bachelor of Applied Science (B.A.Sc.) in Biochemistry and Molecular Biology from the University of the West Indies, Mona, completed in 2005.
Leadership Development Program
Lloye Dillon participated in a two-year leadership development program at Bristol Myers Squibb. This program provided him with rotational experiences across various critical functions, including clinical development, regulatory affairs, and medical safety, equipping him with a comprehensive understanding of drug development and regulatory processes.